RNAi inhibition of alpha-ENaC expression
First Claim
Patent Images
1. A composition comprising an iRNA agent comprising a first strand and a second strand, wherein:
- a. the sequence of the first strand is the sequence of SEQ ID NO;
1511, and the sequence of the second strand is the sequence of SEQ ID NO;
1512;
orb. the sequence of the first strand is the sequence of SEQ ID NO;
1637, and sequence of the second strand is the sequence of SEQ ID NO;
1638.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to compositions and methods for modulating the expression of alpha-ENaC, and more particularly to the downregulation of alpha-ENaC expression by chemically modified oligonucleotides.
37 Citations
23 Claims
-
1. A composition comprising an iRNA agent comprising a first strand and a second strand, wherein:
-
a. the sequence of the first strand is the sequence of SEQ ID NO;
1511, and the sequence of the second strand is the sequence of SEQ ID NO;
1512;
orb. the sequence of the first strand is the sequence of SEQ ID NO;
1637, and sequence of the second strand is the sequence of SEQ ID NO;
1638. - View Dependent Claims (2, 3, 4, 5, 6, 22)
-
-
7. A composition comprising an iRNA agent to alpha-ENaC, wherein the iRNA agent comprises a first strand and a second strand,
wherein the first strand comprises the sequence of SEQ ID NO: - 1511, or SEQ ID NO;
1637, andwherein the second strand comprises the sequence of SEQ ID NO;
1512, or SEQ ID NO;
1638,the composition further comprising an epithelial receptor ligand. - View Dependent Claims (8)
- 1511, or SEQ ID NO;
-
9. A method of treating a human subject having a pathological state mediated at least in part by alpha-ENaC expression, the method comprising the step of administering to the subject a therapeutically effective amount of a composition comprising an iRNA agent comprising a first strand and a second strand, wherein:
-
a. the sequence of the first strand comprises the sequence of SEQ ID NO;
1511, and the sequence of the second strand comprises the sequence of SEQ ID NO;
1512;
orb. the sequence of the first strand comprises the sequence of SEQ ID NO;
1637, and sequence of the second strand comprises the sequence of SEQ ID NO;
1638. - View Dependent Claims (10, 11)
-
-
12. A composition comprising an iRNA agent comprising a first strand and a second strand, wherein:
-
a. the sequence of the first strand comprises the sequence of SEQ ID NO;
1511, and the sequence of the second strand comprises the sequence of SEQ ID NO;
1512;
orb. the sequence of the first strand comprises the sequence of SEQ ID NO;
1637, and the sequence of the second strand comprises the sequence of SEQ ID NO;
1638. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 23)
-
Specification